FMR1 and the Continuum of Primary Ovarian Insufficiency

被引:123
|
作者
Sullivan, Shannon D. [1 ]
Welt, Corrine [2 ]
Sherman, Stephanie [3 ]
机构
[1] Washington Hosp Ctr, Dept Endocrinol, Washington, DC 20010 USA
[2] Massachusetts Gen Hosp, Reprod Endocrine Unit, Boston, MA 02114 USA
[3] Emory Univ, Dept Human Genet, Atlanta, GA 30322 USA
关键词
Primary ovarian insufficiency; premature ovarian failure; fragile X syndrome; Fragile X Mental Retardation 1 (FMR1) gene; FRAGILE-X-SYNDROME; FEMALE PREMUTATION CARRIERS; CEREBELLAR-TREMOR/ATAXIA-SYNDROME; RNA-MEDIATED NEURODEGENERATION; BONE-MINERAL DENSITY; CGG REPEAT NUMBER; CHROMOSOME INACTIVATION; MESSENGER-RNA; FULL MUTATION; NATURAL MENOPAUSE;
D O I
10.1055/s-0031-1280915
中图分类号
R71 [妇产科学];
学科分类号
100211 ;
摘要
Spontaneous 46,XX primary ovarian insufficiency (POI) is a term that describes ovarian dysfunction resulting in a range of abnormalities, from infertility to early menopause as the end stage (overt POI). The most common known genetic cause of 46,XX POI is the expansion of a CGG repeat to 55 to 199 copies in the 5' untranslated region in the X-linked FMR1 gene. This "premutation" is associated with overt POI (FXPOI) in similar to 20% of carrier women. Greater than 200 CGG copies results in methylation of the CGG repeats and subsequent silencing of the FMR1 gene, causing fragile X syndrome. This "full" mutation is not associated with FXPOI. Even in the absence of overt FXPOI, women who carry the premutation may exhibit ovarian dysfunction along a continuum of severity. Evidence also suggests that the severity of FXPOI depends on the CGG repeat length, background modifier genes, and environmental factors (e.g., smoking). This review explores the range of ovarian dysfunction, the mechanisms behind the dysfunction, and the reasons for the variability in presentation in women who carry the FMR1 premutation. Understanding the mechanisms responsible for development of FXPOI is paramount to providing these women with the best overall health care.
引用
收藏
页码:299 / 307
页数:9
相关论文
共 50 条
  • [31] Deregulation of key signaling pathways involved in oocyte maturation in FMR1 premutation carriers with Fragile X-associated primary ovarian insufficiency
    Alvarez-Mora, M. I.
    Rodriguez-Revenga, L.
    Madrigal, I.
    Garcia-Garcia, F.
    Duran, M.
    Dopazo, J.
    Estivill, X.
    Mila, M.
    GENE, 2015, 571 (01) : 52 - 57
  • [32] Understanding decreased fertility in women carriers of the FMR1 premutation: a possible mechanism for Fragile X-Associated Primary Ovarian Insufficiency (FXPOI)
    Peprah, Emmanuel
    REPRODUCTIVE HEALTH, 2014, 11
  • [33] Premature ovarian failure and FMR1 gene mutations: An update
    Conway, G. S.
    ANNALES D ENDOCRINOLOGIE, 2010, 71 (03) : 215 - 217
  • [34] Absence of BRCA/FMR1 Correlations in Women with Ovarian Cancers
    Gleicher, Norbert
    McAlpine, Jessica N.
    Gilks, C. Blake
    Kushnir, Vitaly A.
    Lee, Ho-Joon
    Wu, Yan-Guang
    Lazzaroni-Tealdi, Emanuela
    Barad, David H.
    PLOS ONE, 2014, 9 (07):
  • [35] FMR1 repeat analysis in patients with ovarian dysfunction or failure
    Patsalis, PC
    AMERICAN JOURNAL OF MEDICAL GENETICS, 1999, 83 (04): : 329 - 330
  • [36] FMR1 premutation
    Kang, Seema
    LANCET PSYCHIATRY, 2015, 2 (09): : 781 - 781
  • [37] Can the FMR1 gene predict early ovarian aging?
    Gleicher, Norbert
    Barad, David H.
    WOMENS HEALTH, 2010, 6 (02) : 165 - 169
  • [38] Molecular Characterization of FMR1 Gene by TP-PCR in Women of Reproductive Age and Women with Premature Ovarian Insufficiency
    Deepika Delsa Dean
    Sarita Agarwal
    Deepa Kapoor
    Kuldeep Singh
    Chandra Vati
    Molecular Diagnosis & Therapy, 2018, 22 : 91 - 100
  • [39] Molecular Characterization of FMR1 Gene by TP-PCR in Women of Reproductive Age and Women with Premature Ovarian Insufficiency
    Dean, Deepika Delsa
    Agarwal, Sarita
    Kapoor, Deepa
    Singh, Kuldeep
    Vati, Chandra
    MOLECULAR DIAGNOSIS & THERAPY, 2018, 22 (01) : 91 - 100
  • [40] ATTITUDES TOWARDS POTENTIALLY CARRYING THE FMR1 PREMUTATION: BEFORE VS AFTER TESTING OF NON-CARRIER FEMALES WITH OCCULT PRIMARY OVARIAN INSUFFICIENCY (POI).
    Pastore, L. M.
    Thomas, S. A.
    Penberthy, J. K.
    Antero, M. F.
    Karns, L. B.
    Ventura, K. A.
    FERTILITY AND STERILITY, 2013, 100 (03) : S190 - S191